Promising an exclusive preview of Impressionist and Modernist art, the Alzheimer's Drug Discovery Foundation 5th Annual Connoisseur's Dinner, held at Sotheby's on Thursday, April 28th, did not disappoint. The prominent setting featured a cocktail hour, where Château Bonnet Entre-Deux-Mers Blanc 2009 was served, while works from the current Contemporary Art and Impressionist and Modern Art collections were admired.

ADDF President Nancy Corzine, an early arrival, welcomed VIPS, including Macy's Chairman President/CEO Terry Lundgren, Alexandra Lebenthal, Muffie Potter Aston, Hoda Kotb and Donnie Deutsch, as they entered the long hall leading to the main viewing rooms. Corzine, the first board member of ADDF, is a longtime fighter for an Alzheimer's cure, she has worked for ADDF for six years, having worked previously with the Alzheimer's Foundation for 10 years. She graciously shared her enthusiasm for the foundation's successes and being the Chairman's Award honoree: "I'm very,very honored and very excited. When I was told the figures of the money we have given to scientists to research for a cure for Alzheimer's and they told me it was 45 million dollars in the last five years, which is a little bit more than our government has given for research, I was very happy and very, very, pleased to get the award."

After a brief address from ADDF Co-Chair and Founder Leonard Lauder, a seated dinner followed. Dinner guests. including the aforementioned, as well as the likes of Cornelia Guest, Estee Lauder CEO John Demsey, Evelyn Lauder, Al Taubman, and Emily Frick, were then privy to an exquisite wine tasting where the finest French red and whites were paired, courtesy of Jamie Niven, Chairman of Sotheby's North and South America. As dinner was served, Dr. Howard Fillit addressed guests with further information about Alzheimer's research, followed by a heartfelt speech by Ms. Corzine, in memory of her loving mother Rita Johnson.

The highlight of the evening came when the opportunity to support drug discovery via the funding of Scientist Awardees began. A highly spirited live auction allowed bidding guests to specifically fund Prana Biotechnology Ltd., from Melbourne, Australia, and Yuma Therapeutics, of Brookline Massachusetts. The groundbreaking work of these scientific pioneers serve to make a fundamental change in the future of the disease.

The Fifth Annual Connoisseur's Dinner proved to be an enlightening and upbeat evening. To be in attendance for an unparalleled fine art and dining experience in support of such a worthy cause was a true honor. For additional information on ADDF and its work, please visit the organization online at www.alzdiscovery.org.